Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)

BACKGROUND: Relapsed ependymoma has a dismal prognosis, and the role of chemotherapy at relapse remains unclear. This study prospectively evaluated the efficacy of intensive intravenous (IV) etoposide in patients less than 21 years of age with relapsed intracranial ependymoma (NCT00278252). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Apps, John R, Maycock, Shanna, Ellison, David W, Jaspan, Timothy, Ritzmann, Timothy A, Macarthur, Donald, Mallucci, Conor, Wheatley, Keith, Veal, Gareth J, Grundy, Richard G, Picton, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113139/
https://www.ncbi.nlm.nih.gov/pubmed/35591977
http://dx.doi.org/10.1093/noajnl/vdac053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113139/
https://www.ncbi.nlm.nih.gov/pubmed/35591977
http://dx.doi.org/10.1093/noajnl/vdac053

Ejemplares similares